# Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic

> **NCT02699125** · PHASE4 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 41 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Guanfacine
- **DRUG:** Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT02699125
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-08
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2020-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02699125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02699125, "Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02699125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*